Identifying potentially disruptive biopharmaceutical companies within a sea of less compelling opportunities

The Rapha Capital Mission is to use our unique abilities to identify at the earliest stage, those companies that we believe will go on to profoundly improve peoples’ lives while building great value, from a sea of seemingly indistinguishable, less compelling, opportunities.

Rapha Capital Management is focused on identifying and growing revolutionary ideas in medicine, healthcare and technology before others can see their value.

Rapha Capital Management, LLC, founded in mid-2018, has grown to include 13 managed entities, Rapha Capital Investment I – XIII.

Poseida Therapeutics Logo

Poseida Therapeutics, Inc.

NexImmune Icon

NexImmune, Inc.

Rapha Capital Latest News

April 16, 2021 in Rapha Capital Management

Rapha Capital VC Fund Launch Featured in Fierce Biotech

Written By: Ben Adams, Senior Editor, FierceBiotech Life science venture capital firm Rapha Capital Management has launched its first managed venture capital fund with a target raise of $100M and…
Read More
April 15, 2021 in Rapha Capital Management

Rapha Capital Management Announces First Managed Venture Fund Focused on Investment in Early-Stage Biotech Startups

- Rapha Capital BioVentures (RCBV) Fund, with a target of $100M, builds on Rapha Capital’s successful history guiding the advancements of target biotech investments -  - RCBV Fund plans to…
Read More
April 6, 2021 in FIZE Medical Ltd, Portfolio, Rapha Capital Management

FIZE Medical Completes $5.3 Million Series A Financing

Rapha Capital Management (RCM LLC) Joined by Mendham Investment Group (MIG FZ LLC) in Leading the Financing FIZE's Novel iUO™ Device Conquers the Last Frontier in Patient Monitoring Rapha Capital's…
Read More